Latest News

Mayville Engineering Company, Inc. ( NYSE:MEC ) shareholders would be excited to see that the share price has had a...

Emerald Holding, Inc. ( NYSE:EEX ) is about to trade ex-dividend in the next four days. The ex-dividend date is one...

The FuelCell Energy, Inc. ( NASDAQ:FCEL ) share price has softened a substantial 28% over the previous 30 days, handing...

Shareholders might have noticed that Sensient Technologies Corporation ( NYSE:SXT ) filed its quarterly result this...

We feel now is a pretty good time to analyse Amaroq Ltd.'s ( CVE:AMRQ ) business as it appears the company may be on...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

National CineMedia, Inc. ( NASDAQ:NCMI ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one...

A-Mark Precious Metals, Inc. ( NASDAQ:AMRK ) shareholders might be concerned after seeing the share price drop 10% in...

Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see...

Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

Whilst it may not be a huge deal, we thought it was good to see that the Myers Industries, Inc. ( NYSE:MYE...

Even though Xos, Inc. ( NASDAQ:XOS ) has fallen by 13% over the past week , insiders who sold US$124k worth of stock...

Key Insights Significant control over Aquestive Therapeutics by retail investors implies that the general public has...

GoPro, Inc. ( NASDAQ:GPRO ) shares have retraced a considerable 25% in the last month, reversing a fair amount of their...

With the business potentially at an important milestone, we thought we'd take a closer look at BioRestorative...

Primech Holdings Ltd. ( NASDAQ:PMEC ) shareholders won't be pleased to see that the share price has had a very rough...

Madrigal Pharmaceuticals (MDGL) remains in the red, with losses widening at a 15.3% annual rate over the last five years and net profit margins not improving in that period. Looking ahead, analysts forecast annual revenue growth of 34.8% and earnings growth of 67.2% per year, setting the company on a path to profitability within three years. This represents a much faster trajectory than the US market’s projected 10.5% revenue growth. With shares trading below an estimated fair value and the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Ever found yourself wondering if Liquidia’s explosive growth means it’s a bargain or a bubble? Let’s break down whether there’s still value left for investors. This stock has been on a roll lately, soaring 20.6% in the past week, up 24.4% over the month, and a massive 130.7% year-to-date, topping off a 167.6% gain in the past year. Recent momentum goes beyond simple trading swings. Just last week, Liquidia announced a favorable regulatory breakthrough on its lead...

AmpliTech Group, Inc. ( NASDAQ:AMPG ) shares have retraced a considerable 28% in the last month, reversing a fair...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Halozyme Therapeutics (HALO) posted net profit margins of 47.9%, a significant jump from last year’s 41.4%, as earnings growth for the year hit 51.7%. This figure is twice its five-year average of 20.8% per year. Looking ahead, analysts expect earnings and revenue to continue rising by around 11.6% annually. The company’s price-to-earnings ratio of 13.4x sits comfortably below both the US biotech average of 16.9x and peers at 19.6x. Investors are eyeing the combination of strong...

Insiders who acquired US$347.5k worth of Jasper Therapeutics, Inc.'s ( NASDAQ:JSPR ) stock at an average price of...